Clinical trial
Buprenorphine Dose Alteration Study - 1
NCT00000219 · University of Vermont, Other · Completed
Key facts
| NCT number | NCT00000219 |
|---|---|
| Title | Buprenorphine Dose Alteration Study - 1 |
| Official title | Buprenorphine Dose Alteration Study |
| Lead sponsor | University of Vermont, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine |
| Enrollment | 0 |
| Start date | Dec 1, 1991 |
| Completion | Jul 1, 2001 |
| First posted | Sep 21, 1999 |
| Last update posted | May 6, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: